ArticleCancer reports (Hoboken, N.J.)2022

Modified bi-weekly cetuximab-cisplatin and 5-FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients.

Amichay Meirovitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.